MariMed
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MariMed generated cash of $7,910,000, which is more than the previous year. Cash used in financing activities reached the amount of $22,983,000 last year. Net change in cash is therefore $4,908,000.
Cash Flow
| 2014 | -692.53K | -379.66K | 2.05M |
|---|---|---|---|
| 2015 | -392.88K | -3.50M | 3.07M |
| 2016 | -197.93K | -3.34M | 3.94M |
| 2017 | 1.27M | -20.60M | 20.04M |
| 2018 | -2.90M | -40.06M | 45.79M |
| 2019 | -24.13M | -12.53M | 33.31M |
| 2020 | 3.38M | -4.46M | 3.34M |
| 2021 | 35.85M | -16.62M | 7.45M |
| 2022 | 7.31M | -26.24M | -1.01M |
| 2023 | 7.91M | -25.98M | 22.98M |
MRMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.73M | 29.68M | 2.99M | 738.68K | 4.10M | 1.29M | 569.35K | 160.85K | 988.26K | 8.53K |
Operating activities | ||||||||||
Net income | -16.03M | 13.61M | 7.62M | 2.42M | -81.88M | -13.30M | -1.02M | 321.16K | -1.84M | -7.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.57M | 4.71M | 2.78M | 2.18M | 1.19M | 657.85K | 362.69K | 265.74K | 1.20M | 20K |
Stock-based compensation expense | 1.02M | 6.33M | 13.44M | 990.59K | 223.14K | 0 | 1.21M | 163.57K | 45.94K | 35.99K |
| Deferred income tax benefit | 1.02M | 6.33M | 13.44M | 990.59K | 223.14K | 0 | 1.21M | 163.57K | 45.94K | 35.99K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.16M | -6.90M | -4.69M | -5.98M | -37.70M | -4.07M | -920.87K | -601.50K | -473.41K | -50.07K |
Inventories | -5.82M | -5.38M | -2.93M | -5.61M | -495.39K | -4.42M | -1.32M | -656.03K | 2.06M | -313.46K |
Accounts payable | 2.37M | 1.02M | 104.61K | 1.07M | 632.47K | 963.08K | 2.35M | 341.29K | 59.73K | 507.05K |
Cash generated by operating activities | 7.91M | 7.31M | 35.85M | 3.38M | -24.13M | -2.90M | 1.27M | -197.93K | -392.88K | -692.53K |
Investing activities | ||||||||||
Purchases Of Investments | -261K | 0 | -692.07K | 0 | -2.68M | -30M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -20.13M | -12.74M | -18.56M | -4.94M | -9.97M | -8.92M | -21.01M | -3.36M | -3.04M | -402.66K |
Acquisitions Net | -4.11M | -13.64M | -10K | -255K | -211.82K | -786.50K | 370K | 0 | 0 | 0 |
Cash generated by investing activities | -25.98M | -26.24M | -16.62M | -4.46M | -12.53M | -40.06M | -20.60M | -3.34M | -3.50M | -379.66K |
Financing activities | ||||||||||
Common Stock Issued | 109K | 10K | 23M | 76K | 2.75M | 31.87M | 6.58M | 406.15K | 1.50M | 0 |
Payments for dividends | -158K | -259K | -410K | -308.95K | -474.22K | 0 | -577.73K | -399.83K | -8.86K | 0 |
Repurchases of common stock | 0 | 300K | -23M | 0 | 0 | 15.63M | 0 | 3.40M | 0 | 0 |
Repayments of term debt | 26.37M | 1.23M | -16.45M | -3.87M | 29.14M | -814.14K | 12.26M | -175K | 1.2M | 0 |
Cash used in financing activities | 22.98M | -1.01M | 7.45M | 3.34M | 33.31M | 45.79M | 20.04M | 3.94M | 3.07M | 2.05M |
Net Change In Cash | 4.90M | -19.94M | 26.68M | 2.26M | -3.36M | 2.81M | 720.87K | 408.49K | -1.14M | 979.73K |
Cash at end of period | 14.64M | 9.73M | 29.68M | 2.99M | 738.68K | 4.10M | 1.29M | 569.35K | -160.85K | 988.26K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |